Skip to main content
Premium Trial:

Request an Annual Quote

Tethis See.d Blood Sample Prep Platform

Tethis, a Milan, Italy-based liquid biopsy technology firm, has launched See.d, a universal blood sample prep platform for liquid biopsy. The research-use-only platform performs completely automated and standardized preparation of a blood sample at the point of collection. The platform processes fresh blood collected in EDTA tubes, and automates separation of plasma from cellular fraction, red blood cell lysis and removal, white blood cell dispensation and fixation on SBS slides, and plasma recovery in tubes. At the end of the process, the SBS slides with a fixed monolayer of all white blood cells is made available, and the relative plasma aliquot is provided in a separate tube, Tethis said. The SBS slides are compatible with all analytical pathology techniques, including cytology, immunocytochemistry, immunofluorescence, and fluorescence in situ hybridization for morphological and biomarker-based analysis, the company added. In addition, the plasma is stable for several days and ready for cell-free DNA extraction without any further centrifugation steps, the company said.

Tethis is currently validating the platform for CE-IVD marking, developing liquid biopsy tests, and seeking partnerships with diagnostic and drug-development companies, it said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.